Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Necuparanib, a multi-targeting heparan sulfate mimetic, targets tumor and stromal compartments in pancreatic cancer.

MacDonald A, Priess M, Curran J, Guess J, Farutin V, Oosterom I, Chu CL, Cochran E, Zhang L, Getchell K, Lolkema M, Schultes BC, Krause S.

Mol Cancer Ther. 2018 Nov 6. pii: molcanther.0417.2018. doi: 10.1158/1535-7163.MCT-18-0417. [Epub ahead of print]

PMID:
30401693
2.

Intravital characterization of tumor cell migration in pancreatic cancer.

Beerling E, Oosterom I, Voest E, Lolkema M, van Rheenen J.

Intravital. 2016 Nov 18;5(3):e1261773. doi: 10.1080/21659087.2016.1261773. eCollection 2016.

3.

Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance.

Houthuijzen JM, Oosterom I, Hudson BD, Hirasawa A, Daenen LGM, McLean CM, Hansen SVF, van Jaarsveld MTM, Peeper DS, Jafari Sadatmand S, Roodhart JML, van de Lest CHA, Ulven T, Ishihara K, Milligan G, Voest EE.

FASEB J. 2017 May;31(5):2195-2209. doi: 10.1096/fj.201601248R. Epub 2017 Feb 9.

4.

Increased Plasma Levels of Chemoresistance-Inducing Fatty Acid 16:4(n-3) After Consumption of Fish and Fish Oil.

Daenen LG, Cirkel GA, Houthuijzen JM, Gerrits J, Oosterom I, Roodhart JM, van Tinteren H, Ishihara K, Huitema AD, Verhoeven-Duif NM, Voest EE.

JAMA Oncol. 2015 Jun;1(3):350-8. doi: 10.1001/jamaoncol.2015.0388.

PMID:
26181186
5.

Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response.

Houthuijzen JM, Daenen LG, Roodhart JM, Oosterom I, van Jaarsveld MT, Govaert KM, Smith ME, Sadatmand SJ, Rosing H, Kruse F, Helms BJ, van Rooijen N, Beijnen JH, Haribabu B, van de Lest CH, Voest EE.

Nat Commun. 2014 Nov 12;5:5275. doi: 10.1038/ncomms6275.

PMID:
25387467
6.

'To stretch or not to stretch in children with cerebral palsy'.

Gorter JW, Becher J, Oosterom I, Pin T, Dyke P, Chan M, Shevell M.

Dev Med Child Neurol. 2007 Oct;49(10):797-800; author reply 799. No abstract available.

Supplemental Content

Loading ...
Support Center